Duchenne Muscular Dystrophy in Egypt
How patients in Egypt access treatment for duchenne muscular dystrophy via Named Patient Program.
About Duchenne Muscular Dystrophy
Neuromuscular
Treatment access in Egypt
Egypt's EDA permits personal-use import of non-registered drugs under physician supervision; process is paperwork-heavy but viable.
For patients in Egypt with duchenne muscular dystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with duchenne muscular dystrophy in Egypt
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Egypt and confirm US supply.
- Treating physician in Egypt issues prescription and justification.
- We file Egypt-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Egypt.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.